Practical HP-F5: Oncolytic Viruses (2 w) and Gene Therapy (1 w)
Type: Practical with Student Seminar
Week 1 - 2: Oncolytic Viruses
Date: 13.02.-24.02.2012
Hosts/Supervisors: Sascha Bossow, Christiane Dinsart, Antonio Marchini, Dirk Nettelbeck, Jürg Nüesch, Jean Rommelaere, Guy Ungerechts (contact: d.nettelbeck@dkfz.de)
Topics:
© dkfz.de Virotherapy represents a novel modality for cancer treatment based on tumor-selective virus infection, replication and spread (therefore also called Viral Oncolysis). Key advantages of this strategy are the implementation of a distinct means of cancer cell killing, amplification of the therapeutic agent in the patients’ tumor, and the opportunity to engineer the virus drug to match specific applications (for example virus capsid modification for targeted cell entry, insertion of therapeutic genes into the viral genome).
Content:
© dkfz.de Principles of viral oncolysis as well as different oncolytic viruses will be introduced in a morning seminar by the group leaders of DKFZ virotherapy groups. The students will be provided with recent literature, which they will present in the seminar. Practical work will be performed in groups of two students in the different DKFZ virotherapy groups. Students will apply molecular biology, immunology, cell biology and virology techniques to address a scientific topic of oncolytic virus development or characterization.
Week 3: Gene Therapy
Date: 27.02.-02.03.2012
Host: Dirk Grimm (contact: dirk.grimm@bioquant.uni-heidelberg.de)
